2030 targets | 2024 Achievements | ||
---|---|---|---|
Total CO₂ emissions (compared to 2022)*1 | 42% reduction for Scope 1 & 2 | Scope 1 & 2: 13.4% reduction | |
2024-2025 targets | 2024 Achievements | ||
Over all (Life cycle) | 3% per-year average improvement in lifecycle CO₂ emissions improvement index per product | Annual average: 102% worsening | |
Products | 3% per-year average improvement in raw materials and use CO₂ emissions improvement index per product | Annual average: 102% worsening | |
2025 target | 2024 Achievements | ||
Operation Sites *2 | Energy consumption per basic unit: 2.4% | Head office in japan | 13% improvement |
Ako Office | 4% improvement | ||
Total waste generation per basic unit: 1% | Head office in japan | 1% improvement | |
Ako Office | 12% improvement | ||
Water usage per basic unit: Maintained from previous year | Head office in japan | 2% deterioratin | |
Ako Office | 44% improvement | ||
Emissions of controlled chemical substance per basic unit: 1% | Head office in japan | 2% improvement | |
Ako Office | ±0% improvement |
"Canon": Represents the entire group, including Canon Inc. and all of its consolidated subsidiaries.
"Canon Inc.": Represents Canon Inc. alone.
“Canon Medical Systems”: Represents the entire group, including Canon Medical Systems Corporation and all of its consolidated subsidiaries.
"Canon Medical Systems Corporation": Represents Canon Medical Systems Corporation alone.
The information on this website is not intended for consumers. It is directed exclusively for healthcare professionals and persons who are engaging in purchasing or the business of wholesaling therapeutic goods (in accordance with the Therapeutic Goods Advertising Code Instrument 2021).
By selecting “Continue” you are indicating that you are the intended audience. Click “Cancel” to be redirected to the Canon Medical Systems global website.
© Canon Medical Systems ANZ Pty Limited.
© Canon Medical Systems ANZ Pty Limited.